Please provide your email address to receive an email when new articles are posted on . A combined therapy of phosphodiesterase type 5 — or PDE5 — inhibitors and other treatments was associated with ...

Futura Medical has reported phase 3 data on its topical erectile dysfunction treatment MED3000, teeing it up to file for FDA approval of the therapy as an over-the-counter medicine by the end of the ...

Source: Getty Images Six months after receiving low-intensity extracorporeal shock wave therapy nearly 52% of men reported having satisfactory sexual intercourse, a study found. Low-intensity ...

Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical company focusing on men’s health therapeutics. In an interview with Benzinga, Fady Boctor, the President and Chief Commercial Officer of ...

CINCINNATI (WKRC) – These pandemic times appear to have been very challenging on our relationships, both physically and emotionally. That’s led some to seek new solutions. If one of those solutions ...

I’m a 40 year old male living with HIV since 2002. I have been doing very well with that and taking my medications daily. I also have hypertension and diabetes. As I am getting older I am having more ...

Source: Getty Images In a randomized trial, investigators compared low-intensity shock save therapy with a sham procedure in men with vasculogenic erectile dysfunction. Low-intensity shock wave ...

December 1, 2006 -- The first human trial of gene transfer therapy for erectile dysfunction (ED) indicates that gene therapy that lasts for months and eliminates the patient's need for on-demand drugs ...